微信
Facebook 
分享链接
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia
Hehlmann R*; Lauseker M; Jung Munkwitz S; Leitner A; Muller M C; Pletsch N; Proetel U; Haferlach C; Schlegelberger B; Balleisen L; Hanel M; Pfirrmann M; Krause S W; Nerl C; Pralle H; Gratwohl A; Hossfeld D K; Hasford J; Hochhaus A; Saussele S
Journal of Clinical Oncology, 2011, 29(12): 1634-1642.
期刊论文被引：270浏览：1681